Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer Myfembree sNDA accepted by USFDA for review

Ruchika Sharma6 Jun 2022 2:15 PM IST

MYFEMBREE was approved in the U.S. in 2021 for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women with...

Karkinos Healthcare launches HPV test CerviRaksha priced at Rs 2499

Ruchika Sharma6 Jun 2022 1:26 PM IST

CerviRaksha HPV test identifies the high-risk HPV-16 and HPV-18 genotypes individually.

Sun Pharma plans to increase field force in India by 10 percent in current fiscal

Ruchika Sharma6 Jun 2022 12:30 PM IST

Replying to a query, Ganorkar termed the intended increase in the field force as "more like an organic growth".

USFDA nod to Zydus Lifesciences Famotidine Tablets

Ruchika Sharma6 Jun 2022 11:36 AM IST

It is used to prevent and treat heartburn and other symptoms caused by excessive acid in the stomach (acid indigestion).

DCGI asks all Blood banks to register on e-RaktKosh

Ruchika Sharma5 Jun 2022 6:00 PM IST

New Delhi: The apex drug regulator, Drugs Controller General of India (DCGI) has recently issued an advisory to all the blood banks operating in...

Bristol Myers Squibb withdraws supplemental biologics license application for Reblozyl for Non-transfusion Dependent (NTD) Beta Thalassemia

Ruchika Sharma5 Jun 2022 5:00 PM IST

Reblozyl, a first-in-class therapeutic option, is currently approved in the United States, European Union and Canada to address transfusion-dependent...

Phase 3 SHINE results show postive results for IMBRUVICA (ibrutinib) in Mantle Cell Lymphoma

Ruchika Sharma5 Jun 2022 3:00 PM IST

MCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.

DCGI nod to Biological E Corbevax as heterologous COVID booster

Ruchika Sharma5 Jun 2022 12:00 PM IST

BE's CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster.

Bristol Myers Squibb to acquire Turning Point Therapeutics for USD 76.00 per share

Ruchika Sharma5 Jun 2022 9:30 AM IST

New York: Bristol Myers Squibb and Turning Point Therapeutics, Inc. have announced a definitive merger agreement under which Bristol Myers...

Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US

Ruchika Sharma5 Jun 2022 9:00 AM IST

BYOOVIZ is the first biosimilar launch in the U.S. under the Biogen and Samsung Bioepis' partnership.

Pfizer appoints Annaliesa Anderson as Senior Vice President

Ruchika Sharma4 Jun 2022 4:52 PM IST

New York: Pfizer Inc. has announced that Annaliesa Anderson, Ph.D., has been appointed Senior Vice President and Head of the Company's Vaccine...

Thyrocare inaugurates Regional Processing Lab in Ahmedabad

Ruchika Sharma4 Jun 2022 3:51 PM IST

The new Regional Processing Lab at Ahmedabad has a capacity to process 3000 samples in a day.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok